Sign inJoin waitlistJoin the waitlist

Ravi Vij

Professor of Medicine · Washington University/B-JH/SLCH Consortium

Credentials: · · · · · · ·

History

Washington University/B-JH/SLCH Consortium
Present
Washington University/B-JH/SLCH Consortium
Present

Hematology and Medical Oncology
1994–1997
Internal Medicine
1991–1994
Univ Of Delhi
1987–1991

Research

Initial genome sequencing and analysis of multiple myeloma
Nature · 2011 · 1,207 citations
Lenalidomide after stem-cell transplantation for multiple myeloma
New England Journal of Medicine · 2012 · 909 citations
TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes
New England Journal of Medicine · 2016 · 716 citations

John DiPersio
110 papers
Keith Stockerl-Goldstein
61 papers
PW
Peter Westervelt
51 papers · 2 as a fellow
Mark Schroeder
45 papers
Geoffrey Uy
43 papers · 3 as a fellow
Camille Abboud
40 papers
Amanda Cashen
37 papers
HK
Hanna Khoury
31 papers
Sundar Jagannath
31 papers
Douglas Adkins
29 papers
Shaji Kumar
28 papers
David Siegel
27 papers

Clinical trials

Isatuximab, Bendamustine, and Prednisone in Refractory Multiple Myeloma
Principal investigator · Terminated · Phase 1
Washington University School of Medicine
2020–2024
Elotuzumab, Pomalidomide, & Dexamethasone (Elo-Pom-Dex) With Second Autologous Stem Cell Transplantation for Relapsed Multiple Myeloma
Principal investigator · Active not recruiting · Phase 2
Washington University School of Medicine
2017–2027
Phase II Study of IRD (Ixazomib, Lenalidomide, Dexamethasone) Post Autologous Stem Cell Transplantation Followed by Maintenance Ixazomib or Lenalidomide for Multiple Myeloma
Principal investigator · Active not recruiting · Phase 2
Washington University School of Medicine
2015–2026
Phase II Study of V-BEAM Conditioning Regimen Prior to Second Autologous Stem Cell Transplantation
Principal investigator · Terminated · Phase 2
Washington University School of Medicine
2012–2013